Here are the responses to our December, 2020 Quick Question: "What therapeutic does your center use for hemophilia A patients with inhibitors who bleed during emicizumab therapy?" There were only 6 voters
Posts - Bleeding Disorders
Jan 2, 2021 9:27am
Dec 21, 2020 6:52pm
Dec 1, 2020 5:30pm
Our December, 2020 Quick Question addresses the uncommon incidence of breakthrough bleeds in hemophilia A patient who are being treated with emicizumab [HEMLIBRA], the immunotherapeutic that bypasses factor VIII. Treatment may become an issue in severe hemophilia in which patients develop inhibitors.
Dec 1, 2020 5:19pm
Our November, 2020 Quick Question attracted 37 participants. Here is the stem: "Which VWF activity assay is preferred at your facility [check 10-31-20 post]?" The selections were...